Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Singanayagam, A. Akram, J. Chalmers, A. Hill (United Kingdom). Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia. Eur Respir J 2010; 36: Suppl. 54, 3845

Member's Comments

No comment yet.

Related content which might interest you: Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Inhaled corticosteroid therapy on admission of hospitalized patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 243s Year: 2002 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019 Year: 2019 Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019 Year: 2019 Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Source: Eur Respir J 2010; 36: 751-757 Year: 2010 Use of long acting bronchodilators and inhaled corticosteroids within 30-days of discharge in older adults hospitalized for AECOPD Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009 Risks of pneumonia in asthmatic patients taking inhaled corticosteroids Source: Annual Congress 2010 - Management of airway disease Year: 2010 Association of COPD inhaled  medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – COPD management Year: 2017 Change of inhaled medications during hospital admissions for acute exacerbation of COPD Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? Source: Eur Respir J 2011; 37: 1-3 Year: 2011 Characteristics of COPD patients treated with inhaled corticosteroid in primary care Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006